Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Lowered by Wall Street Zen

Posted by Francis Steltz on Oct 27th, 2026

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Sunday, Wall Street Zen reports.

A number of other analysts also recently issued reports on the company. KeyCorp started coverage on Guardian Pharmacy Services in a report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price target for the company. Truist Financial upped their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Weiss Ratings downgraded Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday. Finally, Oppenheimer increased their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Nine investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Read Our Latest Stock Report on GRDN

Guardian Pharmacy Services Stock Down 0.8%

NYSE GRDN opened at $39.11 on Friday. Guardian Pharmacy Services has a 52 week low of $26.34 and a 52 week high of $48.33. The firm has a 50 day moving average of $40.88 and a two-hundred day moving average of $37.82. The stock has a market capitalization of $1.95 billion, a PE ratio of 37.98, a price-to-earnings-growth ratio of 2.06 and a beta of 0.03.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.03. The business had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, equities research analysts expect that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Nisa Investment Advisors LLC raised its position in Guardian Pharmacy Services by 53.5% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after buying an additional 366 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Guardian Pharmacy Services by 105.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock worth $97,000 after acquiring an additional 1,229 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Guardian Pharmacy Services by 3.2% in the first quarter. Bank of New York Mellon Corp now owns 69,432 shares of the company’s stock valued at $2,615,000 after acquiring an additional 2,177 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in shares of Guardian Pharmacy Services by 12.6% in the third quarter. Park Avenue Securities LLC now owns 20,863 shares of the company’s stock valued at $851,000 after acquiring an additional 2,338 shares in the last quarter. Finally, Arizona State Retirement System boosted its holdings in shares of Guardian Pharmacy Services by 53.0% in the second quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after acquiring an additional 2,907 shares in the last quarter.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.